Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-12-05
1993-12-21
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514343, A61K 31445, A61K 3144
Patent
active
052721558
ABSTRACT:
Pharmaceutical compositions comprising a therapeutically effective amount of (+) 2-methylpiperidine and a pharmaceutically-acceptable carrier or diluent, as well as to a method of treating cognitive, neurological and mental disorders, which are characterized by decreased cholinergic function in humans and lower mammals, by administration of (+)2-methylpiperidine, optionally with a nicotinic agonist.
REFERENCES:
patent: 3035977 (1962-05-01), Abood
Chemical Abstracts (109: 50124h) 1988.
Arneric Stephen P.
Decker Michael W.
Abbott Laboratories
Elder Richard A.
Gorman, Jr. Edward H.
Waddell Frederick E.
Weddington Kevin E.
LandOfFree
(+)-2-methylpiperidine as modulator of cholinergic systems does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with (+)-2-methylpiperidine as modulator of cholinergic systems, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and (+)-2-methylpiperidine as modulator of cholinergic systems will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-309254